{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T03:43:07Z","timestamp":1780544587134,"version":"3.54.1"},"reference-count":38,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,23]],"date-time":"2023-08-23T00:00:00Z","timestamp":1692748800000},"content-version":"vor","delay-in-days":1970,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"name":"Ipsen Pharmaceuticals","award":["None"],"award-info":[{"award-number":["None"]}]},{"name":"Sartain Lanier Family Foundation","award":["None"],"award-info":[{"award-number":["None"]}]}],"content-domain":{"domain":["neurotherapeuticsjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurotherapeutics"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1007\/s13311-018-0620-9","type":"journal-article","created":{"date-parts":[[2018,3,14]],"date-time":"2018-03-14T14:35:54Z","timestamp":1521038154000},"page":"452-458","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Pilot Single-Blind Trial of AbobotulinumtoxinA in Oromandibular Dystonia"],"prefix":"10.1016","volume":"15","author":[{"given":"Laura M.","family":"Scorr","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael R.","family":"Silver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Hanfelt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elaine","family":"Sperin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan","family":"Freeman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.A.","family":"Jinnah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stewart A.","family":"Factor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1007\/s13311-018-0620-9_bib1","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/2054-7072-1-3","article-title":"The phenomenology and natural history of idiopathic lower cranial dystonia","volume":"1","author":"Termsarasab","year":"2014","journal-title":"J Clin Mov Disord"},{"key":"10.1007\/s13311-018-0620-9_bib2","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/B978-0-444-52014-2.00037-9","article-title":"Adult-onset dystonia","volume":"100","author":"Evatt","year":"2011","journal-title":"Handbook of clinical neurology"},{"key":"10.1007\/s13311-018-0620-9_bib3","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.parkreldis.2005.07.007","article-title":"A comparison of jaw-closing and jaw-opening idiopathic oromandibular dystonia","volume":"12","author":"Singer","year":"2006","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1007\/s13311-018-0620-9_bib4","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.parkreldis.2010.04.007","article-title":"Lingual protrusion dystonia: frequency, etiology and botulinum toxin therapy","volume":"16","author":"Esper","year":"2010","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1007\/s13311-018-0620-9_bib5","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1002\/mds.870030302","article-title":"Epidemiology of focal and generalized dystonia in Rochester, Minnesota","volume":"3","author":"Nutt","year":"1988","journal-title":"Mov Disord"},{"key":"10.1007\/s13311-018-0620-9_bib6","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1212\/01.WNL.0000090463.05980.59","article-title":"Prevalence of primary focal and segmental dystonia in Oslo","volume":"61","author":"Le","year":"2003","journal-title":"Neurology"},{"key":"10.1007\/s13311-018-0620-9_bib7","first-page":"509","article-title":"Meige syndrome: primary and secondary forms","volume":"50","author":"Tolosa","year":"1988","journal-title":"Adv Neurol"},{"key":"10.1007\/s13311-018-0620-9_bib8","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/ene.13133","article-title":"Epidemiological, clinical and genetic aspects of adult onset isolated focal dystonia in Ireland","volume":"24","author":"Williams","year":"2017","journal-title":"Eur J Neurol"},{"key":"10.1007\/s13311-018-0620-9_bib9","doi-asserted-by":"crossref","first-page":"2102","DOI":"10.1212\/WNL.53.9.2102","article-title":"Botulinum toxin A in patients with oromandibular dystonia: long-term follow-up","volume":"53","author":"Tan","year":"1999","journal-title":"Neurology"},{"key":"10.1007\/s13311-018-0620-9_bib10","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/1746-160X-2-47","article-title":"Eating dysfunction associated with oromandibular dystonia: clinical characteristics and treatment considerations","volume":"2","author":"Papapetropoulos","year":"2006","journal-title":"Head Face Med"},{"key":"10.1007\/s13311-018-0620-9_bib11","doi-asserted-by":"crossref","first-page":"44","DOI":"10.3109\/00207454.2011.558260","article-title":"The broadening application of chemodenervation in X-linked dystonia-parkinsonism (Part II): an open-label experience with botulinum toxin-A (Dysport(R)) injections for oromandibular, lingual, and truncal-axial dystonias","volume":"121 Suppl 1","author":"Rosales","year":"2011","journal-title":"Int J Neurosci"},{"key":"10.1007\/s13311-018-0620-9_bib12","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1111\/j.1749-4486.2010.02194.x","article-title":"Oromandibular dystonia questionnaire (OMDQ-25): a valid and reliable instrument for measuring health-related quality of life","volume":"35","author":"Merz","year":"2010","journal-title":"Clin Otolaryngol"},{"key":"10.1007\/s13311-018-0620-9_bib13","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1001\/archotol.127.4.389","article-title":"Impact on quality of life of botulinum toxin treatments for spasmodic dysphonia and oromandibular dystonia","volume":"127","author":"Bhattacharyya","year":"2001","journal-title":"Archives of Otolaryngology-Head & Neck Surgery"},{"key":"10.1007\/s13311-018-0620-9_bib14","doi-asserted-by":"crossref","first-page":"E9","DOI":"10.1177\/014556131109000210","article-title":"Jaw-opening dystonia: Quality of life after botulinum toxin injections","volume":"90","author":"Charous","year":"2011","journal-title":"Ear Nose Throat J"},{"key":"10.1007\/s13311-018-0620-9_bib15","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/j.1468-1331.2006.01441.x","article-title":"Botulinum toxin in blepharospasm and oromandibular dystonia: comparing different botulinum toxin preparations","volume":"13 Suppl 1","author":"Bhidayasiri","year":"2006","journal-title":"Eur J Neurol"},{"key":"10.1007\/s13311-018-0620-9_bib16","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1055\/s-0036-1571952","article-title":"Botulinum Toxin Treatment of Blepharospasm, Orofacial\/Oromandibular Dystonia, and Hemifacial Spasm","volume":"36","author":"Karp","year":"2016","journal-title":"Semin Neurol"},{"key":"10.1007\/s13311-018-0620-9_bib17","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1016\/j.bjoms.2016.06.028","article-title":"Management of oromandibular dystonia with botulinum A toxin: a series of cases","volume":"54","author":"Teemul","year":"2016","journal-title":"Br J Oral Maxillofac Surg"},{"key":"10.1007\/s13311-018-0620-9_bib18","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.toxicon.2012.12.004","article-title":"Evidence-based review and assessment of botulinum neurotoxin for the treatment of movement disorders","volume":"67","author":"Hallett","year":"2013","journal-title":"Toxicon"},{"key":"10.1007\/s13311-018-0620-9_bib19","doi-asserted-by":"crossref","first-page":"3078","DOI":"10.1002\/lary.23265","article-title":"Oromandibular dystonia: long-term management with botulinum toxin","volume":"123","author":"Sinclair","year":"2013","journal-title":"Laryngoscope"},{"key":"10.1007\/s13311-018-0620-9_bib20","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1136\/jnnp.68.2.186","article-title":"Tardive and idiopathic oromandibular dystonia: a clinical comparison","volume":"68","author":"Tan","year":"2000","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1007\/s13311-018-0620-9_bib21","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1002\/mds.25475","article-title":"Phenomenology and classification of dystonia: a consensus update","volume":"28","author":"Albanese","year":"2013","journal-title":"Mov Disord"},{"key":"10.1007\/s13311-018-0620-9_bib22","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s13311-013-0221-6","article-title":"Designing clinical trials for dystonia","volume":"11","author":"Galpern","year":"2014","journal-title":"Neurotherapeutics"},{"key":"10.1007\/s13311-018-0620-9_bib23","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1002\/mds.21625","article-title":"Validation of a swallowing disturbance questionnaire for detecting dysphagia in patients with Parkinson's disease","volume":"22","author":"Manor","year":"2007","journal-title":"Mov Disord"},{"key":"10.1007\/s13311-018-0620-9_bib24","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1002\/mds.10377","article-title":"Rating scales for dystonia: a multicenter assessment","volume":"18","author":"Comella","year":"2003","journal-title":"Mov Disord"},{"key":"10.1007\/s13311-018-0620-9_bib25","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1002\/mds.21152","article-title":"Validation of a new scale for the evaluation of sialorrhea in patients with Parkinson's disease","volume":"22","author":"Perez Lloret","year":"2007","journal-title":"Mov Disord"},{"key":"10.1007\/s13311-018-0620-9_bib26","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1212\/WNL.35.1.73","article-title":"Validity and reliability of a rating scale for the primary torsion dystonias","volume":"35","author":"Burke","year":"1985","journal-title":"Neurology"},{"key":"10.1007\/s13311-018-0620-9_bib27","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1212\/WNL.37.4.616","article-title":"Botulinum A toxin for cranial-cervical dystonia: a double-blind, placebo-controlled study","volume":"37","author":"Jankovic","year":"1987","journal-title":"Neurology"},{"key":"10.1007\/s13311-018-0620-9_bib28","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1097\/PHM.0b013e3181bc0c78","article-title":"Effect of botulinum toxin injection on nocturnal bruxism: a randomized controlled trial","volume":"89","author":"Lee","year":"2010","journal-title":"Am J Phys Med Rehabil"},{"key":"10.1007\/s13311-018-0620-9_bib29","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1177\/000348948909800202","article-title":"Botulinum toxin injection for the treatment of oromandibular dystonia","volume":"98","author":"Blitzer","year":"1989","journal-title":"Ann Otol Rhinol Laryngol"},{"key":"10.1007\/s13311-018-0620-9_bib30","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1097\/00007611-199705000-00012","article-title":"Tongue protrusion dystonia: treatment with botulinum toxin","volume":"90","author":"Charles","year":"1997","journal-title":"South Med J"},{"key":"10.1007\/s13311-018-0620-9_bib31","doi-asserted-by":"crossref","first-page":"231","DOI":"10.5334\/tohm.194","article-title":"Clinical, Etiological, and Therapeutic Features of Jaw-opening and Jaw-closing Oromandibular Dystonias: A Decade of Experience at a Single Treatment Center","volume":"4","author":"Gonzalez-Alegre","year":"2014","journal-title":"Tremor and other hyperkinetic movements"},{"key":"10.1007\/s13311-018-0620-9_bib32","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1002\/mds.870090606","article-title":"Reliability among neurologists in the severity assessment of blepharospasm and oromandibular dystonia: a multicenter study","volume":"9","author":"Defazio","year":"1994","journal-title":"Mov Disord"},{"key":"10.1007\/s13311-018-0620-9_bib33","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.toxicon.2015.09.010","article-title":"Botulinum neurotoxins for the treatment of focal dystonias: Review of rating tools used in clinical trials","volume":"107","author":"Del Sorbo","year":"2015","journal-title":"Toxicon"},{"key":"10.1007\/s13311-018-0620-9_bib34","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1007\/s00415-016-8185-1","article-title":"Effect of botulinum toxin treatment on quality of life in patients with isolated lingual dystonia and oromandibular dystonia affecting the tongue","volume":"263","author":"Nastasi","year":"2016","journal-title":"Journal of neurology"},{"key":"10.1007\/s13311-018-0620-9_bib35","first-page":"181","article-title":"Clinical evaluation of bidirectional torticollis","volume":"5","author":"Truong","year":"1990","journal-title":"Mov Disord"},{"key":"10.1007\/s13311-018-0620-9_bib36","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1002\/mds.26085","article-title":"Dysport and Botox at a ratio of 2.5:1 units in cervical dystonia: a double-blind, randomized study","volume":"30","author":"Yun","year":"2015","journal-title":"Mov Disord"},{"key":"10.1007\/s13311-018-0620-9_bib37","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1002\/mds.25582","article-title":"Diffusion, spread, and migration of botulinum toxin","volume":"28","author":"Ramirez-Castaneda","year":"2013","journal-title":"Mov Disord"},{"key":"10.1007\/s13311-018-0620-9_bib38","article-title":"Diffusion of botulinum toxins.","volume":"2","author":"Brodsky","year":"2012","journal-title":"Tremor Other Hyperkinet Mov (N Y)"}],"container-title":["Neurotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13311-018-0620-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13311-018-0620-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747923015763?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747923015763?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13311-018-0620-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T07:09:14Z","timestamp":1761808154000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1878747923015763"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4]]},"references-count":38,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,4]]}},"alternative-id":["S1878747923015763"],"URL":"https:\/\/doi.org\/10.1007\/s13311-018-0620-9","relation":{},"ISSN":["1878-7479"],"issn-type":[{"value":"1878-7479","type":"print"}],"subject":[],"published":{"date-parts":[[2018,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pilot Single-Blind Trial of AbobotulinumtoxinA in Oromandibular Dystonia","name":"articletitle","label":"Article Title"},{"value":"Neurotherapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1007\/s13311-018-0620-9","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2018 The American Society for Experimental NeuroTherapeutics, Inc. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}